In the last couple of years, a record number ofpersonalized therapeutic products were approved in the US, establishing anurgent need for companion diagnostics and causing many drug developers toactively seek external support and expertise
Roots Analysis is pleased to announce the publication of its recentstudy, titled, “CompanionDiagnostics Development Services Market, 2020-2030”
The report features an extensive study of the currentmarket landscape, offering an informed opinion on the likely adoption ofdiagnostic development services over the next decade. It features an in-depthanalysis, highlighting the capabilities of the various stakeholders in thisdomain. In addition to other elements, the study includes:
§ A detailed assessment of the current market landscape of morethan 180 companies offering companion diagnostics services.
§ Tabulated profiles of companion diagnostics serviceproviders (shortlisted on the basis of the number of services offered).
§ An analysis of the partnerships that have been establishedin this domain, in the recent past.
§ A list of stakeholders generated based on a detailedanalysis of a set of relevant parameters, which are anticipated to partner withcompanion diagnostics services providers in the foreseen future.
§ A detailedcompetitiveness analysis of companion diagnostics services providers, featuringinsightful pictorial summaries and representations.
§ A comparative analysis of the needs of differentstakeholders involved in this domain.
§ A discussion on various steps of the development operationsof a companion diagnostic and the cost requirements across each of the stages.
§ An analysis of completed, ongoing and planned clinicaltrials featuring disease-specific biomarkers.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
- Type of Services
§ Feasibility Studies
§ Assay Development
§ Analytical Validation
§ Clinical Validation
§ Manufacturing
- Type of Analytical Technique
§ in situ hybridization / Immunohistochemistry
§ Next Generation Sequencing
§ Polymerase Chain Reaction
§ Others
- Key Geographical Region
§ North America
§ Europe
§ Asia-Pacific and the Rest of the World
Transcripts of interviews held with the following seniorlevel representatives of stakeholder companies
§ Anton Iliuk (President, Chief Technology Officer TymoraAnalytical Operations)
§ Paul Kortschak (Senior Vice President, Novodiax)
§ Pablo Ortiz (Chief Executive Officer, OWL Metabolomics)
§ Lawrence M. Weiss (Chief Scientific Officer, NeoGenomicsLaboratories)
Keycompanies covered in the report
§ Almac Diagnostic Services
§ Asuragen
§ BARD1 Life Sciences
§ BioMarCare Technologies
§ Covance
§ Gencurix
§ Geneuity
§ Leica Biosystems
§ Macrogen
§ MD Biosciences
§ R-Biopharm
§ ResearchDx
§ Tepnel Pharma Services
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html
Other Recent Offerings
1. NeoantigenTargeted Therapies Market, 2019-2030
2. BispecificAntibody Therapeutics Market (4th Edition), 2019-2030
3. GlobalStem Cells Market: Focus on Clinical Therapies, 2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
